Report #2829775

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Feb 25, 2025
Onset: Feb 26, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

HeadachePain in extremity

Symptom narrative

sore arm; headache; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 25-FEB-2025, the patient received Shingrix. On 26-FEB-2025, 1 days after receiving Shingrix, the patient experienced pain in arm (Verbatim: sore arm) and headache (Verbatim: headache). The outcome of the pain in arm and headache were not resolved. It was unknown if the reporter considered the pain in arm and headache to be related to Shingrix. It was unknown if the company considered the pain in arm and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 26-FEB-2025 The patient received a subsequent dose of Shingrix and experienced sore arm and headache.